Cancer hope

PERTH-based Medi-tech Research Limited may be on the brink of a major advance in cancer therapy with its hyaluronic acid technology for the delivery of anti-cancer drugs.

The Ethics Commit-tee at Royal Melbourne Hospital has approved human trials in bowel cancer patients.

Ethics Committee chairman and eminent oncologist Richard Fox has joined Meditech’s board of directors to monitor and assist in both the human trials and ongoing research.